Cargando…

Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging

Detalles Bibliográficos
Autores principales:	Törüner, Murat, Toprak, Selami Koçak, Mızrak, Kiraz, Yıldırım, Yasin, Bay, Meltem, Ayyıldız, Erol, İlhan, Osman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2013
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878464/ https://www.ncbi.nlm.nih.gov/pubmed/24385792 http://dx.doi.org/10.4274/Tjh.2012.0186

Ejemplares similares

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
por: Erkmen Uyar, Mehtap, et al.
Publicado: (2013)

Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
por: Raghuwanshi, Babita, et al.
Publicado: (2020)

Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
por: Kırcalı, Ekin, et al.
Publicado: (2022)

LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS
por: Krznarić, Željko, et al.
Publicado: (2019)

Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
por: Toprak, Selami Koçak
Publicado: (2013)

Past, present and future in low-risk myelodysplastic syndrome
por: Toprak, Selami Kocak
Publicado: (2022)

Peripheral Leukocytapheresis Attenuates Acute Lung Injury Induced by Lipopolysaccharide In Vivo
por: He, Zhi-Gao, et al.
Publicado: (2012)

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
por: Cengiz Seval, Guldane, et al.
Publicado: (2023)

Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
por: Fernandez-Sojo, Jesus, et al.
Publicado: (2022)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Epigenetics of Inflammatory Bowel Diseases
por: Törüner, Murat, et al.
Publicado: (2023)

Thrombosis and risk factors: A comment
por: Toprak, Selami Koçak, et al.
Publicado: (2012)

Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis
por: Itou, Minoru, et al.
Publicado: (2009)

Get Off on the Right Foot: How to Plan an Efficient Leukocytapheresis to Collect T Cells for CAR T-Cell Manufacturing
por: Piñeyroa, Juan A., et al.
Publicado: (2022)

sEPCR Levels in Chronic Myeloproliferative Diseases and Their Association with Thromboembolic Events: A Case-Control Study
por: Atalay, Figen, et al.
Publicado: (2014)

Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
por: Kırcalı, Ekin, et al.
Publicado: (2023)

Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy
por: Tek, Ibrahim, et al.
Publicado: (2013)

Aspergillus Thyroiditis after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ataca, Pinar, et al.
Publicado: (2015)

P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE ON 110 PATIENTS
por: Seval, Guldane Cengiz, et al.
Publicado: (2022)

An Experimental Study of Radiation Effect on Normal Tissue: Analysis of HIF-1α, VEGF, eIF2, TIA-1, and TSP-1 Expression
por: Aktaş, Caner, et al.
Publicado: (2013)

Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Güler, Tülay, et al.
Publicado: (2014)

A Randomized Comparison of Hemoglobin Content-Based Versus Standard (Unit-Based) Red Blood Cell Transfusion Policy
por: Atilla, Erden, et al.
Publicado: (2017)

A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis
por: Kobayashi, Taku, et al.
Publicado: (2017)

Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
por: Narlı Özdemir, Zehra, et al.
Publicado: (2021)

Management of Kikuchi-Fujimoto Disease Using Glucocorticoid: A Case Report
por: Yalcin, Selim, et al.
Publicado: (2011)

PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
por: Yilmaz, Hulya, et al.
Publicado: (2023)

Does Thrombocyte Size Give Us an Idea about Thrombocytosis Etiology?
por: Toprak, Selami Kocak, et al.
Publicado: (2012)

Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
por: Sakai, Masahiro, et al.
Publicado: (2023)

Synthesis, Characterization of a New Polyacrylic Acid Superabsorbent, Some Heavy Metal Ion Sorption, the Adsorption Isotherms, and Quantum Chemical Investigation
por: Savaskan Yilmaz, Sevil, et al.
Publicado: (2020)

Coexistence of a Ghon Complex, Pott’s Disease, and Hip Arthritis in a Child
por: Yigit, Ozgul, et al.
Publicado: (2016)

Encouraging
Publicado: (1869)

Encouragement
Publicado: (1875)

Encouraged
Publicado: (1893)

Encouragement
Publicado: (1859)

Progress in Health Literacy—Encouraging, and Not So Encouraging
por: Weiss, Barry D.
Publicado: (2017)

Emergency medicine residency fact board: Why our attempt to encourage on-shift learning failed
por: Sokol, Kimberly, et al.
Publicado: (2019)

Rituximab-Related Reversible Hepatocellular Damage
por: Toprak, Selami K., et al.
Publicado: (2012)

Lipoprotein apheresis efficacy and challenges: single center experience
por: Özdemir, Zehra Narlı, et al.
Publicado: (2022)

Encouraging innovation
por: Hyman, Anthony A.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gia6c74knjan472qfke1mte68f